This is ARPA-H’s first major deliverable of the White House Initiative on Women’s Health Research since the Agency was created in 2022 as part of President Biden’s bipartisan Unity Agenda, seeking to advance and accelerate health solutions.
The U.S. Department of Health and Human Services' (HHS) Advanced Research Projects Agency for Health (ARPA-H) recently announced a $100 million investment toward the Biden-Harris Administration’s initiative on women's health research, aiming to advance transformative research and development in women's health.
This is ARPA-H’s first major deliverable of the White House Initiative on Women’s Health Research since the Agency was created in 2022 as part of President Biden’s bipartisan Unity Agenda, seeking to advance and accelerate health solutions.
According to ARPA-H Director Renee Wegrzyn in an interview with Axios, the investment is “part of federal efforts to close gender gaps in research, which supporters say have led to insufficient funding for endometriosis, MS and other conditions that disproportionately affect women...”
Wegrzyn added the agency's program managers plan to develop focus areas for the women's health research efforts and solicit ideas for potential solutions, which could range from medical treatments and detection tools to new research models or gene-editing technology.
“Barriers to women’s health research can and must be lifted by organizations like ARPA-H,” Wegrzyn also said in an ARPA-H release. “The ARPA-H Sprint for Women's Health intends to fundamentally change the trajectory of women’s health care and radically accelerate the next generation of discoveries that range from early laboratory proofs of concept that may impact future generations, to products that are ready to be commercialized and launched to start improving women’s health today.”
First Lady Jill Biden claimed the White House Initiative will change how our nation approaches and funds women’s health research as it’s “always been underfunded, and as a result, we know far too little about our own health.”
Last Wednesday, HHS Secretary Xavier Becerra visited Boston, Massachusetts, for an event with the First Lady to announce the $100 million investment.
“The issue of healthcare for women has faced challenges longer than any of us have been alive: scientific challenges, clinical challenges, political challenges, and now this week, down in Alabama, another legal challenge,” said Becerra in remarks at the event. “The key here is that President Joe Biden made [ARPA-H's announcement] possible: $100 million. That is everything. And with the First Lady launching this White House initiative on women's health research, we have the focus we need. And so at the Department of Health and Human Services, she had us at hello: we are ready to go.”
The issue in Alabama was also announced last week where the Alabama Supreme Court's ruling granting personhood to embryos sparked confusion across the state.
This prompted the University of Alabama at Birmingham (UAB), the largest healthcare system in the state, to pause all IVF treatments, citing concerns about potential legal consequences for patients and physicians following standard IVF care.
Study Reveals Patients Benefit More with Female Doctors — More Particularly Female Patients
April 30th 2024Understanding how physician sex contributes to these disparities is crucial as evidence on the impact of physician sex on clinical outcomes remains limited, especially around patient sex.
Read More
The proposed rule for the fiscal year (FY) 2025 Inpatient Prospective Payment System and Long-Term Care Hospital Prospective Payment System introduces strategies to improve the well-being of Medicare beneficiaries, including efforts to tackle social determinants of health, create more robust emergency readiness and enhance maternal healthcare.
Read More
The IRA’s Impact on Women in Medicare
April 2nd 2024In 2025, the out-of-pocket cap and other Part D related provisions in the Inflation Reduction Act are projected to save women in Medicare an average of 28% in out-of-pocket costs, according to a new analysis from the Office of the Assistant Secretary for Planning and Evaluation.
Read More
With aging populations, osteoporosis rates are set to increase, and researchers are looking for the next innovative drug to help prevent or manage the bone disease as there is currently no drug that completely does so effectively, according to a recent study published in Advanced Science.
Read More